Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - xingming+deng
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Small Molecule for Treatment-Resistant Lung Cancer
Application Small molecule agonist for treating cancers involving KRAS mutations. Key Benefits Specifically targets mutant KRAS in non-small-cell lung carcinoma (NSCLC). Selective for mutant KRAS lung cancer cells over normal cells. Non-toxic to normal cells. Market Summary Lung cancer patients with KRAS mutation(s) have a poor prognosis due...
Published: 2/13/2025
|
Inventor(s):
Xingming Deng
Keywords(s):
Oncology Treatments
,
Small Molecule
Category(s):
TechPub Algolia > Drug Discovery
,
TechPub Algolia > Therapeutics